SCHEMBL30129591

SCHEMBL30129591

CC(=O)O[C@H](C)CNc1nnc(-c2ccc(C(F)(F)F)cc2C(F)(F)F)cc1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 2/20 0.44
TRPV3 Q8NET8 3/20 0.39
IL1B P01584 7/20 0.35
CYP1A2 P05177 1/20 0.34
TSHR P16473 1/20 0.34
KDM4E B2RXH2 1/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
CYP2C19 P33261 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CYP2C9 P11712 1/20 0.32
SCN9A Q15858 1/20 0.32
CES2 O00748 1/20 0.32
TLR2 O60603 1/20 0.32
TLR1 Q15399 1/20 0.32
KCNH2 Q12809 1/20 0.32
BACE1 P56817 1/20 0.31
CFTR P13569 1/20 0.31
PSMB11 A5LHX3 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30041007 0.76 NLRP3 (0.48) NLRP3TRPV3KDM4EUSP2ALDH1A1
SCHEMBL30042431 0.76 NLRP3 (0.54) NLRP3TRPV3IL1BCYP1A2KCNH2
SCHEMBL32682445 0.74 NLRP3 (0.47) NLRP3TRPV3KDM4EALDH1A1HPGD
SCHEMBL30041215 0.73 NLRP3 (0.48) NLRP3TRPV3IL1BKDM4EALDH1A1
Hydrochloric Acid SCHEMBL32682444 0.73 NLRP3 (0.47) NLRP3TRPV3IL1BKDM4EALDH1A1
SCHEMBL7449680 0.72 CFTR (0.46) CYP1A2KDM4EUSP2ALDH1A1HPGD
SCHEMBL30042437 0.71 NLRP3 (0.45) NLRP3TRPV3IL1BCYP1A2TSHR
SCHEMBL30129718 0.70 NLRP3 (0.42) NLRP3TRPV3IL1BSCN9AKCNH2
SCHEMBL7444613 0.70 SMN1; SMN2 (0.43) KDM4EALDH1A1HPGDCFTR
SCHEMBL30041472 0.70 NLRP3 (0.64) NLRP3IL1BKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4129986-A1 SUBSTITUTED PYRIDAZINE COMPOUND Astellas Pharma Inc. (JP) 2023-02-08 EP disclosed